Table 2.
Comparison of general characteristics of MF( +) and MF( −) groups after PSM
| MF( +) | MF( −) | p | |
|---|---|---|---|
| Age | 68.72 + 10.04 | 68.72 + 10.04 | 1 |
| Male (%) | 63 (52.5) | 63 (52.5) | 1 |
| Diabetes duration above 10 years (%) | 64 (53.3) | 56 (46.7) | 0.302 |
| Glucose (median (IQR)) | 175.2 (134.5 − 251) | 190 (138 − 259) | 0.507 |
| eGFR(median (IQR)) | 53.9 (38.8 − 80.6) | 61.5 (34.1 − 86.8) | 0.648 |
| ALT (median (IQR)) | 25 (16 − 42) | 19 (11 − 30) | 0.003 |
| HBA1C (median (IQR)) | 8.35 (7.05 − 9.57) | 7.55 (6.57 − 9.65) | 0.214 |
| Hypertension (%) | 89 (74.2) | 88 (73.3) | 0.883 |
| COPD-asthma (%) | 20 (16.7) | 25 (20.8) | 0.408 |
| CAD (%) | 48 (40.0) | 50 (41.7) | 0.793 |
| CVD(%) | 15 (12.5) | 11 (9.2) | 0.406 |
| Hyperlipidaemia (%) | 51 (42.5) | 39 (32.5) | 0.110 |
| ARF(%) | 55 (45.8) | 51 (42.5) | 0.603 |
| ICU Admission (%) | 23 (19.2) | 35 (29.2) | 0.07 |
| In-hospital mortality (%) | 19 (15.8) | 29 (24.2) | 0.107 |
| Post-discharge mortality (%) | 16 (15.8) | 22 (24.2) | 0.148 |
| Overall mortality (%) | 35 (29.2) | 51 (42.5) | 0.031 |
| Number of hospitalization days (median (IQR)) | 7 (5–12.5) | 8.5 (5–16.5) | 0.071 |
| Follow-up days count | 140 (88.7 − 213.7) | 127.5 (39.7 − 211.5) | 0.216 |
COPD chronic obstructive pulmonary disease, CAD coronary artery disease, CVD cerebrovascular disease, ARF acute renal failure, ICU intensive care unit, eGFR estimated glomerular filtration rate